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ABSTRACT: The rate and extent of drug dissolution and
absorption from solid oral dosage forms is highly dependent
upon the volumes and distribution of gastric and small
intestinal water. However, little is known about the time
courses and distribution of water volumes in vivo in an
undisturbed gut. Previous imaging studies oﬀered a snapshot
of water distribution in fasted humans and showed that water
in the small intestine is distributed in small pockets. This study
aimed to quantify the volume and number of water pockets in
the upper gut of fasted healthy humans following ingestion of a
glass of water (240 mL, as recommended for bioavailability/
bioequivalence (BA/BE) studies), using recently validated
noninvasive magnetic resonance imaging (MRI) methods.
Twelve healthy volunteers underwent upper and lower abdominal MRI scans before drinking 240 mL (8 ﬂuid ounces) of water.
After ingesting the water, they were scanned at intervals for 2 h. The drink volume, inclusion criteria, and fasting conditions
matched the international standards for BA/BE testing in healthy volunteers. The images were processed for gastric and intestinal
total water volumes and for the number and volume of separate intestinal water pockets larger than 0.5 mL. The fasted stomach
contained 35 ± 7 mL (mean ± SEM) of resting water. Upon drinking, the gastric ﬂuid rose to 242 ± 9 mL. The gastric water
volume declined rapidly after that with a half emptying time (T50%) of 13 ± 1 min. The mean gastric volume returned back to
baseline 45 min after the drink. The fasted small bowel contained a total volume of 43 ± 14 mL of resting water. Twelve minutes
after ingestion of water, small bowel water content rose to a maximum value of 94 ± 24 mL contained within 15 ± 2 pockets of 6
± 2 mL each. At 45 min, when the glass of water had emptied completely from the stomach, total intestinal water volume was 77
± 15 mL distributed into 16 ± 3 pockets of 5 ± 1 mL each. MRI provided unprecedented insights into the time course, number,
volume, and location of water pockets in the stomach and small intestine under conditions that represent standard BA/BE
studies using validated techniques. These data add to our current understanding of gastrointestinal physiology and will help
improve physiological relevance of in vitro testing methods and in silico transport analyses for prediction of bioperformance of
oral solid dosage forms, particularly for low solubility Biopharmaceutics Classiﬁcation System (BCS) Class 2 and Class 4
compounds.
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■ INTRODUCTION
Solid oral delivery (e.g., tablets and capsules) is the most
frequently used route of administration for pharmaceutical drug
products due to patient convenience and cost eﬀectiveness.
Despite their ubiquity, development of solid oral dosage forms
that perform eﬀectively and consistently in patient populations
can be challenging due to the complex environment of drug
dissolution and absorption in the gastrointestinal (GI) tract.
Along with other important physiological parameters such as
buﬀer species, pH, bile salts, gastric emptying rate, motility, and
shear rates, the small bowel water content (SBWC) has the
potential to inﬂuence greatly the rate and extent of drug
dissolution and absorption in the GI tract, or “oral
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bioperformance”.1 Using GastroPlus, Sutton, for example,
showed that intestinal water volumes had a large impact on
the predictive power of simulations of the mean plasma
concentration proﬁles of four solubility-limited compounds.2
To obtain reasonable predictions of oral bioperformance,
scientists must design meaningful in vitro dissolution tests and
mechanistic drug transport models that capture the range of
SBWC in humans.
Of special interest is the SBWC in fasted humans after
ingestion of a glass of water (240 mL). This volume of water is
typical of relative bioavailability (BA) and bioequivalence (BE)
studies performed by innovator or generic pharmaceutical
companies who wish to ﬁle drug applications with drug
regulatory agencies in the United States, Europe, and Japan
(FDA, EMA, and MHLW, respectively). These in vivo
pharmacokinetic studies are designed to demonstrate the rate
and extent to which a drug substance is absorbed from a drug
product and becomes available at the site of action (BA study)
or the absence of a signiﬁcant diﬀerence in the rate or extent of
absorption between two diﬀerent drug products containing the
same drug substance (BE study).3 For BA and BE studies in
fasted humans, the U.S. Food and Drug Administration (FDA)
guidelines recommend that the drug product be ingested with
240 mL of water (8 U.S. ﬂuid ounces),3,4 and the EMA and
MHLW suggest giving a constant volume of at least 150 mL of
water.5,6 In addition, the solubility class boundary for the
Biopharmaceutics Classiﬁcation System (BCS) Class 2 and
Class 4 compounds is deﬁned as the highest dose strength that
is soluble in 250 mL of aqueous media over the pH range of 1−
7.5.7,8 Testing solubility in this volume of liquid is likely to be
physiologically relevant for a drug that dissolves in the stomach,
but it is unclear whether or not it is physiologically relevant for
a drug that dissolves primarily in the small intestine.
Studies using aspiration, gamma scintigraphy, and magnetic
resonance imaging (MRI) show that a dose of water with a
volume varying between about 240 and 800 mL empties rapidly
from the fasted human stomach, with a gastric half emptying
time between approximately 8 and 18 min.9−14 The liquid
emptied from the stomach enters the proximal small bowel,
with subsequent absorption into the intestinal membrane or
transit down the length of the intestine. Positron emission
tomography (PET) and MRI data show that the average SBWC
in fasted humans varies between 80 and 300 mL,15−19 but little
data is available postwater consumption, particularly following
water ingested immediately prior to imaging.
Recent studies used PET to assess ﬂuid distribution in the
gastrointestinal tract of a rat model.20 A recent MRI study in
humans has drawn great attention to the possibility that the
liquid in the small intestine exists in discrete liquid “pockets”.15
MRI is the ideal tool to carry out serial and noninvasive
imaging of gastrointestinal function21 and, in particular, liquids
in the undisturbed gastrointestinal tract. Gastric emptying
measurements have been long established and validated,22−24
and small bowel water volume measurements have been
validated against naso-duodenal infusion.25
This study aimed to characterize the time course of volume
and distribution of liquid in the stomach and small bowel of
healthy subjects before and after ingestion of a 240 mL dose of
water using MRI.
■ MATERIALS AND METHODS
Study Design. This study had a single-center, one-way,
open-label design consisting of a screening visit and one test
day. The primary outcome measure was the volume of freely
mobile small bowel water (SBWC, in mL) with time. The
secondary outcome measures were the volume of liquid in the
stomach (in mL), the number of water pockets in the small
bowel, and their volumes (in mL) with time as well as the
location of water pockets by abdominal quadrant.
The subjects arrived at 8:00 am at the site in a fasted state.
Eligibility was conﬁrmed. They then consumed the 240 mL
water study drink at approximately 9:00 am. Gastric and
intestinal water contents were measured using upper and lower
MRI scans acquired just before (baseline) and after ingestion of
the test drink at predetermined intervals for up to 2 h
postingestion as shown in Supporting Information Figure S1.
Baseline scans also veriﬁed that the stomach of the participants
appeared fasted. After this, the scanner bed was moved out of
the bore and the participants drank quickly the 240 mL water
drink sitting up on the scanner bed, after which they were
repositioned supine, and imaging started promptly. The MRI
scans were more frequent for the ﬁrst half an hour when gastric
emptying was expected to be faster. During the initial half an
hour time the participants remained supine inside the scanner,
and after that they were taken out of the scanner and
repositioned supine for upper and lower abdominal MRI scans
at 15 min intervals. In between scanning, the participants were
asked to sit upright in a room next to the scanner. As such, the
posture of the participants was standardized in all studies. After
the ﬁnal scan, the subjects were oﬀered some light refreshments
(e.g., water, coﬀee, tea, biscuits) before they were discharged.
This study was approved by the local Medical School
Research Ethics Committee and was conducted according to
Good Clinical Practice principles. All volunteers gave written
informed consent. There were no adverse events during the
study. This protocol was registered on ClinicalTrials.gov with
identiﬁer NCT01792453.
Study Participants. Twelve healthy volunteers took part in
the study. They were 4 male and 8 female, 21.3 ± 0.6 years old
with body mass index (BMI) of 22.1 ± 0.6 kg/m2. The
inclusion criteria and lifestyle restrictions were designed to be
as close as possible to the U.S. Food and Drug Administration
(FDA) guidelines for the assessment of Fasted Treatments in
healthy volunteers.4 Inclusion criteria comprised: being healthy;
male or female; between 18 and 55 years of age; of normal
range BMI,6 which the UK NHS classiﬁes as having BMI
between 18.5 and 24.9 kg/m2 for the adult population, in
agreement with the World Health Organization (WHO) and
the U.S. Centers for Disease Control and Prevention (CDC);
nonsmokers; without a history of alcohol or drug abuse; with
no history of gastrointestinal disorders or gastrointestinal
surgery; not on any medication likely to aﬀect gastrointestinal
function. In addition the subjects had to be suitable for MRI
scanning (e.g., no metal implants). Subjects doing strenuous
physical exercise (e.g., competition training) or night shift work
were excluded6 as were excluded subjects who drank more than
21 units of alcohol in a typical week. The subjects were asked to
avoid caﬀeine (tea, coﬀee, and cola) for 18 h prior to their study
day and alcohol for 24 h prior to their study day. They were
also asked to take no dietary supplements for 24 h prior to their
study day. They were asked to eat an evening meal of similar
size to that usually consumed on the night before scanning and
to start fasting no later than 10 pm that evening (i.e., at least 10
h fasting). Water was allowed but not after 7 am of the study
day after which the subjects are asked not to eat or drink
anything until arriving at the study site at 8 am. During the test
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day, they were not allowed to eat or drink anything other than
the test water drink until the study was ﬁnished and were asked
to minimize activity.
Magnetic Resonance Imaging. MRI scanning was
performed on a research dedicated 1.5 T Philips Achieva
MRI scanner (Philips Healthcare, Eindhoven, The Nether-
lands). Volunteers were positioned supine with a 16-element
parallel imaging receiver coil wrapped around the abdomen.
Two MRI sequences were used to image the abdomen at each
time point. A balanced turbo ﬁeld echo (TrueFISP or bTFE)
sequence with in-plane resolution 2.0 × 1.77 mm2, ﬁeld of view
FOV 400 × 320 mm2, echo time TE/repetition time TR 1.5/3.0
ms, acceleration factor 2.0, and ﬂip angle = 80° acquired 50
multislice contiguous, 5 mm, transverse slices in a single breath-
hold. This was used to measure gastric volumes. A single shot,
fast spin echo sequence (rapid acquisition with relaxation
enhancement, RARE) was acquired in a single breath-hold 24
coronal images with in-plane resolution interpolated to 0.78
mm × 0.78 mm and a slice thickness of 7 mm, with no gap
between slices (TR = 8000 ms, TE = 320 ms, acquired
resolution = 1.56 mm × 2.90 mm). This sequence yields high
intensity signals from areas with ﬂuid and little signal from body
tissues and is used to measure small bowel water content. Each
image set was acquired on an expiration breath-hold with
duration of 13 and 24 s, respectively, monitored using a
respiratory belt.
Data Analysis. The data are shown as mean ± standard
error of the mean (SEM). Analyses were carried out using the
Per Protocol (PP) population as planned. Volumes of gastric
contents were measured by a single, experienced operator using
an intensity based, semiautomatic method, which deﬁned the
bright liquid stomach contents on each image slice26 using in-
house software on an IDL platform (IDL 6.4; Research Systems
Inc., Boulder, CO, USA). Plots of volume against time (up to
24 min) were created and used to determine the time to half
empty the initial volume T50%. T50% is referred to as the time
needed for the stomach to empty 50% of its initial content.
This was calculated by ﬁtting the individual gastric emptying
curves to a standard model.26,27 Since the stomach may start
emptying while ingesting the drink, the initial volume V0 in the
gastric emptying model was not set as fasting volume + drink
volume but ﬁtted from the data, improving accuracy. Only a
couple of subjects showed a brief lag time after drink ingestion,
and for these, the standard model parameters were constrained.
The volumes of freely mobile small bowel water (SBWC) were
assessed from the images acquired using the RARE MRI
sequence as previously described and validated.25 Brieﬂy,
regions of interest were drawn manually around the small
bowel on each image excluding regions such as the stomach,
gall bladder, and blood vessels using in-house software on an
IDL platform (IDL 6.4; Research Systems Inc., Boulder, CO,
USA). The software then identiﬁed (in the 3-dimensional
multislice data set) all small bowel regions containing freely
mobile water (e.g., water with intensity above a threshold,
determined from the subject’s cerebrospinal ﬂuid). The sum of
the volumes of all these small bowel regions provided the total
SBWC. To deﬁne the small bowel water pockets, a mask was
generated from the small bowel regions identiﬁed, and a region-
growing algorithm was used to determine the size of each
connected region. The software recoded the number of pockets
and their volume. The pockets were categorized by volume into
predeﬁned pocket “bins”. The ﬁrst bin contained all the
smallest water pockets, from a volume of a single imaging voxel
up to a volume <0.5 mL. The other bins were predeﬁned in the
ranges 0.5−2.5, 2.5−5, 5−10, 10−20, and >20 mL. As the water
pockets are derived from the total SBWC image segmentation,
it follows that the sum of all the pockets’ volumes corresponds
to the total SBWC value at any given time point. Where
indicated, the results for mean number of water pockets and for
mean volume of pockets exclude the smallest “bin” of <0.5 mL.
This action was taken since their contribution to the total
volume is very small and they confuse the display and
interpretation of data due to their large number. The analysis
software also allowed the operator to divide the abdomen into
four anatomical quadrants by placing, in the coronal view, a
crosshair in the middle of the intervertebral disc just below the
kidneys (Supporting Information Figure S2). The quadrants
were named: upper right (containing mostly the proximal
duodenum), upper left (containing mostly distal duodenum
and proximal jejunum), lower left (containing mostly distal
jejunum and proximal ileum), and lower right (containing
mostly distal ileum). The software then produced an additional
output assigning the number of liquid pockets and volumes into
these quadrants, dependent on their center of mass.
Power and Statistical Analysis. The primary outcome
was SBWC so the study was powered to an acceptable error in
the mean estimates of small bowel water volume. Our previous
studies pooled together indicated that the fasting SBWC in
healthy volunteers was 99 mL ± SD of 69 mL, n = 151 subjects.
Using this information it was predicted that, with n = 12
subjects, SBWC could be estimated with a SEM of ±20 mL
with a 90% power and α = 0.05.
Figure 1. Examples of MRI images. Representative examples of MRI images acquired after a 240 mL dose of water in a healthy volunteer. (A) One
axial image of the water drink inside the stomach. (B) One heavily T2 weighted coronal image of the abdomen. In this kind of MRI sequence the
signal from tissue has mostly decayed and only bright signal from freely mobile water is seen. (C) The maximum intensity projection image of all the
individual small bowel water pockets, color coded and extracted from the entire three-dimensional set of panel B and manually segmented.
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Statistical analysis was carried out using Prism 5 (GraphPad
Software Inc., La Jolla, CA). The data were tested for normality
using the Shapiro-Wilk Test. Friedman’s test was used to assess
the signiﬁcance of diﬀerences over time, followed by Dunn’s
multiple comparison test versus baseline values. Diﬀerences
between the mean number of pockets divided by bin size were
assessed using nonparametric Friedman’s test followed by
Dunn’s ntest. A p-value < 0.05 was considered to be statistically
signiﬁcant.
■ RESULTS
The study procedures were very well tolerated and good quality
images were obtained from all subjects. The liquid contents of
the stomach (Figure 1A) and of the small bowel (Figure 1B)
were clearly seen in the MRI images of each subject.
Gastric Volume and Emptying. The fasted stomach
contained 35 ± 7 mL of resting liquid. Upon drinking, the
gastric liquid volume rose to 242 ± 9 mL after 2 min. The
liquid in the stomach appeared as a single continuous water
pocket. Its volume declined rapidly (Figure 2A) with very brief
lag time observed only in a couple of subjects (Supporting
Information Figure S3). The ﬁrst part of the individual gastric
emptying curves was mostly exponential with a mean ﬁtted half
emptying time T50% of 13 ± 1 min. For about half of the
subjects, the second part of the gastric emptying curves
deviated from the initial single exponential with the mean
gastric volume returning back to baseline values 45 min after
the water dose.
Total Small Bowel Water Content (SBWC). The fasting
small bowel contained a total of 43 ± 14 mL water (range of
5−159 mL). After ingestion of the dose of water, the total
SBWC increased signiﬁcantly from baseline (Friedman’s P =
0.002) as shown in Figure 2B. Volumes peaked at 92 ± 24 mL
(range of 15−264 mL) at 12 min after dosing. At 45 min, when
the stomach had completely emptied the ingested water, the
total intestinal liquid volume was 77 ± 15 mL (range of 15−
172 mL), and after this time, the total small SBWC remained
fairly constant around this value. The individual time curves
(Supporting Information Figure S4) showed marked inter-
individual variation.
Small Bowel Water Pockets. The fasting small bowel
water was distributed in 8 ± 1 pockets of 4 ± 1 mL on average
each. After water ingestion, the total number of small bowel
liquid pockets increased signiﬁcantly from baseline (Friedman’s
P = 0.0332) as shown in Figure 3A. The individual time courses
showed a certain degree of interindividual variation (Support-
ing Information Figure S5). At 12 min when the peak total
volume was reached, the number of liquid pockets had risen to
15 ± 1. At 45 min, when the ingested water had emptied from
the stomach completely, the number of pockets was 16 ± 3,
and after this time, the total number of pockets gradually
decreased to values that are statistically not diﬀerent from the
baseline value. The distribution in the number of liquid pockets
on the basis of pocket size bin (Supporting Information Figure
S6) showed that the majority of pockets are small (0.5−2.5 mL
size bin). Before and at all times subsequent to drinking the
dose of water, the percentage of the number of pockets in the
size bin 0.5−2.5 mL was greater than 60%, and the percentage
of the number of pockets in the size bin >20 mL was less than
10%. At all time points there was a signiﬁcant eﬀect of bin size
on number of pockets (Friedman’s p < 0.0001).
Post hoc analysis showed that the number of liquid pockets
in the smaller 0.5−2.5 mL size bin was signiﬁcantly higher than
all the larger bin sizes and that there was no signiﬁcant
diﬀerence between the remaining larger bin sizes.
The fasting small bowel water pockets had a volume of 4 ± 1
mL on average each. The mean pocket volume had a trend to
increase with time to about 7 mL (Figure 3B; individual time
courses in Supporting Information Figure S7) after water
ingestion, but diﬀerences between means were not statistically
signiﬁcant (Friedman’s P = 0.4251). Despite the greatest
number of pockets being in the smallest size bin (0.5−2.5 mL)
as mentioned above, most of the total volume of liquid in the
small intestine was found in fewer pockets in the size range >20
mL. At all times before and after ingestion of water, the liquid
pockets in this size range accounted for over 45% of the total
volume. The actual volumes and numbers of pockets varied
greatly between individuals as shown in Supporting Informa-
tion Figures S5 and S7. Figure 3C shows a comparison between
the mean pocket volume distributions on a number versus a
Figure 2. (A) Mean gastric volume and (B) mean total small bowel water content before and after ingestion of a 240 mL dose of water given at t = 0
min. n = 12 healthy volunteers. Error bars represent ± SEM. Dunn’s multiple comparison test versus baseline value * P < 0.05; ** P < 0.01; *** P <
0.001. Error bars represent ± SEM.
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volume basis calculated again excluding the smallest pocket bin
of <0.5 mL volume in keeping with the previous ﬁgures. For
completeness the corresponding ﬁgure including the smallest
pocket bin of <0.5 mL volume is displayed in Supporting
Information Figure S8. This illustrates that the smallest small
bowel water pockets (<0.5 mL in volume each) constitute only
0.4% of the total small bowel water content, which is the reason
why they have been excluded from some of the ﬁgures in the
article for clarity as their number is high but the percentage of
the total volume very small; hence, their functional contribution
to drug dissolution and absorption will be limited.
Splitting the analysis by abdominal quadrant showed that the
larger amount of small bowel water was consistently located in
the lower quadrants, particularly the lower left (distal jejunum
and proximal ileum) with also higher numbers of water pockets.
The upper right quadrant (proximal duodenum) showed little
water content even during gastric emptying, indicating that
liquid here was absorbed and/or moved forward rapidly. Liquid
volumes increased rapidly from baseline in the upper left (distal
duodenum and proximal jejunum) and then lower left (distal
jejunum and proximal ileum) quadrants followed by a slow rise
in the lower right quadrant (distal ileum). Liquid pocket
volumes were very variable between quadrants making it
diﬃcult to determine trends. The analysis by quadrant is
presented in Supporting Information Figures S9 and S10.
■ DISCUSSION
Knowledge of the volume and distribution of liquid in the
fasted human small intestine as a function of time after
ingestion of 240 mL of water (conditions representing standard
bioequivalence and bioavailability studies) is of great
importance to the pharmaceutical industry. This information
is needed to develop physiologically relevant in vitro tests and in
silico predictions of solid oral drug bioperformance, which can
be used to design robust drug products that perform
successfully during human clinical pharmacokinetic BA and
BE studies. For the current study, the water drink volume,
inclusion criteria, and the fasting conditions were chosen to
Figure 3. Small bowel water pockets before and after ingestion of a 240 mL water dose administered at t = 0 min (excluding all pockets in the
smallest range <0.5 mL). (A) Mean total number of small bowel water pockets. (B) Mean volume of small bowel water pockets. (C) Comparison
between the percentage of the total number of pockets and the percentage of the total volume of each pocket in each volume range at fasting baseline
(before administration of the study drink of water). n = 12 healthy volunteers. Error bars represent ± SEM. Dunn’s multiple comparison test versus
baseline value * P < 0.05.
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match the international standards for fasted state drug testing in
healthy volunteers as far as possible, in order to increase the
relevance of this study to current practices. Although a later
EMA document allows inclusion of overweight subjects (BMI
up to 30 kg/m25), we felt the original inclusion of normal range
only would be easier to map on all the various guidelines. The
subjects had to follow an overnight fasting of at least 10 h, in
accordance with the FDA fasting guidance.4 Water was allowed,
but it was forbidden for 1 h before the study start.4 The EMA
guidelines of overnight fasting6 of at least 8 h before testing are
also in line with the FDA guidance and the current study.5
The results for gastric liquid volume and emptying are in line
with a previous study conducted using a similar volume of
water drink, 300 mL. Steingoetter and co-workers measured
liquid volume in the stomach before and after administration of
300 mL of water using MRI.14 They found the resting volume
to be 28 mL (range of 18−54) prior to water administration,
which agrees with our measured volume of 35 ± 7 mL. They
found gastric liquid volume to be 296 mL (range of 279−323)
immediately after ingestion of 300 mL of water. This volume is
equal to about 90% of the expected volume (resting liquid
volume + administered volume of water), which is in line with
our measured value of 242 ± 9 mL measured after
administering a 240 mL volume of water. The 300 mL water
drink in their study emptied immediately (without a lag phase)
and in an exponential pattern from the proximal and distal
regions of the stomach, with a half emptying time of 16 min
(range of 11−17). Our data conﬁrmed this overall picture with
an initial, rapid exponential emptying and only a couple of
individuals showing a very brief lag phase before emptying.
Yamashita and colleagues used a smaller initial volume of 150
mL of water and used nasogastric aspirates to calculate rate
constants for both emptying and secretion of ﬂuid.28 The half-
life of gastric emptying in that study (4.2 min) was shorter than
our values possibly due to diﬀerences in initial volume and
experimental set up. Their study highlighted the importance of
oro-gastric secretion in determining gastric volumes. We did
not have to estimate this here as one of the advantages of MRI
is that it measures directly the actual volume of liquid in the
stomach, as a balance of input and output, at any given time
point. The participants spent the ﬁrst part of the study supine
due to the MRI scanner conﬁguration. Posture and meal
structure may have an eﬀect on gastric emptying,29 particularly
for liquid meals that layer in the stomach such as mixtures of fat
and water.22 However, in the case of a water drink, it has been
shown that even radical changes in body position do not aﬀect
gastric emptying rate and gastric emptying half times.14
A major objective of the current study was to conﬁrm the
existence of water in discontinuous pockets throughout the
small intestine after administration of a glass of water. Schiller
and co-workers ﬁrst described intestinal water as separated in a
series of pockets and provided an initial overall quantiﬁcation.15
Our study builds on that work using a validated method to
quantify small bowel water using MRI and also provides a
detailed breakdown of liquid pocket size and location in the
small bowel. Another advantage of our study is that, to our
knowledge, it is the ﬁrst quantifying total volume of water in
the stomach and small intestine under conditions representing
BA/BE studies. In addition, previous studies characterizing the
volume of water in the small intestine have been conducted
without administration of water immediately prior to imaging.
Therefore, the question whether small intestinal water volume
would indeed be increased and by how much following
drinking of water remained unanswered. Schiller and co-
workers administered water at intervals leading up to the initial
MRI scan, starting as early as 7 h before and as late as 2 h prior
to the scan, and determined a mean total small intestinal liquid
volume of 105 mL.15 Previous studies from our group for which
volunteers were fasted overnight with no access to water for up
to 8 h before MRI or were allowed a small glass of water but
only 2 h before imaging showed average small intestinal water
volumes of about 80−100 mL.17,19,30 Our study (in which 240
mL of water was given 2 min before imaging and SBWC was
assessed serially for up to 2 h after) conﬁrmed liquid volumes
ranging from 67 ± 17 to 93 ± 24 mL, with a range in individual
values of 10−264 mL, despite recent water administration. The
initial average resting value of 43 ± 14 mL (range of 5−158
mL) was somewhat lower than anticipated from previous
studies, probably due to chance given the small number of
participants. The maximum average value of 93 ± 24 mL
occurred at the point when just under half of the ingested water
had been emptied from the stomach.
Before ingestion of water, there were on average 8 pockets of
4 mL volume each. Shortly after ingestion of water, both the
number and mean volume of pockets roughly doubled
(although the increase in mean pocket volume was not
statistically signiﬁcant), before returning to baseline values after
the dose of water has been completely emptied from the
stomach. At 2 h after ingestion of water an average of 11 ± 2
pockets of 7 ± 2 mL each were present. In their study, Schiller
and co-workers reported a median number of pockets of 4 with
a median volume of 12 mL each for water administered
approximately 2 h earlier, which is roughly half the number of
pockets with twice the volume as we found.
When thinking about the time frame for dissolution and
absorption of a rapidly dissolving immediate release dosage
form, the time period after administration of the dose up to
about 45 min (when the entire contents of the stomach have
been emptied) is critical. During this time frame it was found
that the largest amount of liquid (∼60% of the volume) is
contained in a small number of large pockets, while the number
of smaller pockets (2.5−20 mL) contains about 40% of the
total volume. The smallest pockets analyzed in detail (0.5−2.5
mL) account for less than 5% of the total liquid volume,
whereas the smallest pocket bin (<0.5 mL), represents less the
0.5% of available water. The MRI sequence used is strongly T2
weighted so possible motion and relaxation artifacts are unlikely
to have created artiﬁcial false-positive bright pixels counted as
small pockets of water. There is a possibility that turbulent ﬂow
artifacts would make a large water pocket appear as two (or
more) separate water pockets disconnected. This is, however,
usually associated with a combination of larger volumes and
motion as seen sometimes in the stomach, and we have no
indication that this was the case here for the larger range small
bowel water pockets. The water in the small intestine was
found to be mostly in the lower regions of the small intestine
(the distal jejunum and ileum) in keeping with previous
observations.15 Any water associated with mucus on the surface
of the intestinal epithelium was not taken into account in this
study, as it would not give a measurable signal on the strongly
T2 weighted sequence used in this study, due to its limited
mobility. As it is assumed that the majority of drug particles
dissolve in the freely mobile water, any water contained in the
mucus layer should have a potentially small relative eﬀect on
bulk dissolution rate. While water contained in the mucus layer
and within pockets of <0.5 mL may be important to consider in
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some cases, complete characterization of these regions was not
the focus of this study.
The time course of liquid volumes in the stomach and small
intestine following administration of 240 mL of water has
important implications for predicting the oral bioperformance
of solid dosage forms using both in vitro testing as well as
computational methods. For instance, gastric and intestinal
water volume can signiﬁcantly aﬀect dissolution, the amount of
drug dissolved, precipitation, and absorption kinetics and
therefore the rate of appearance of poorly soluble compounds
in the bloodstream. The information regarding total liquid
volume in the stomach and small intestine and distribution into
individual pockets as determined in this study can be used to
develop in vitro biopredictive dissolution tests, estimate the
potential percentage of a dose soluble in the stomach and small
intestine, and be used as a starting point for development of a
physiological model describing transport and distribution of
liquid throughout the gastrointestinal tract.
The time course of gastric water volume is an important
parameter that can aﬀect the dissolution and precipitation
kinetics of numerous drug substances that dissolve in the
stomach. Knowledge of gastric volume is important for the
purpose of evaluating the maximum percentage of the dose
soluble in the stomach in vivo under conditions representing
BA/BE studies. This study conﬁrms that it would be reasonable
to experimentally determine the fraction of the dose soluble in
a volume of 240−250 mL in vitro, and on the basis of work by
Kalantzi and co-workers, a buﬀer consisting of 0.01 N HCl or
other media simulating gastric liquid could be used for the
analysis.31−34 An understanding of the gastric emptying rate
and pattern is important when conducting in vitro physiological
dissolution testing of numerous compounds, such as those
compounds for which gastric emptying may be a rate-limiting
step to systemic availability or, for low solubility, weakly basic
compounds, which may dissolve extensively in the stomach and
precipitate in the small intestine.35,36 This work suggests that
when conducting in vitro experiments in an apparatus such as
the Artiﬁcial Stomach and Duodenum, which includes a
separate stomach compartment,37 or predicting oral bioper-
formance computationally, that an average ﬁrst-order gastric
emptying rate coeﬃcient of 3.2 h−1 (T50% of 13 min), with a
range of 2.2−6.0 h−1, would be a good starting point for the
analysis.
In vitro dissolution testing is often conducted using large
volumes of dissolution medium, often with the assumption that
intestinal liquid volumes are indeed large, or that a large volume
of dissolution medium is a reasonable substitute to describe in
vivo dissolution of a drug into a smaller volume of medium with
rapid absorption of that drug into the intestinal membrane. In
many cases, such as for some BCS II and IV compounds with
high dose numbers,38 it is important to maintain a physiological
volume of water, which this study would suggest to be about
50−100 mL on average, and include a separate medium (such
as 1-octanol) or compartment in the dissolution test to remove
dissolved drug from the bulk aqueous medium at a
physiologically relevant rate, as can be accomplished using a
two-phase dissolution apparatus.39
While, for practical reasons, using a continuous volume of
aqueous buﬀer in vitro is convenient, the presence of a series of
separate, smaller volumes of water contained within diﬀerent
regions of the small bowel has signiﬁcant implications. One
possible scenario to in vitro dissolution testing or computational
transport modeling would be to assume the dose is equally
distributed among the liquid pockets. However, it is
conceivable that a signiﬁcant portion of the total dose may
be conﬁned to only a few of the liquid pockets. These diﬀerent
scenarios could quite possibly result in substantially diﬀerent
absorption rates due to the signiﬁcantly diﬀerent areas available
for absorption, especially for a poorly soluble drug substance.
Also, when examining the information on number and volume
within one individual rather than on an average basis, one can
observe large variability between subjects, as illustrated in
Figure 4. This phenomenon is likely due to diﬀering fasting
motility, which is highly variable with episodes of intense
activity, the “migrating motor complex” (MMC), followed by
long periods of quiescence. The MMC frequency is known to
be aﬀected by many factors including psychological stressors.40
The volume and number of liquid pockets also has
implications for estimation of the mass of a dose soluble in
the small intestine in vivo under conditions representing BA/BE
studies. As mentioned above, 250 mL is a logical volume for
assessment of the mass of a dose of drug soluble in the
stomach. However, as evidenced by the total volume of liquid
and the distribution of liquid into pockets, this volume may be
too large for estimation of the mass of a dose soluble in the
small intestine. A more reasonable approach may be to use a
volume of about 80−100 mL for an assessment.
The information on distribution of liquid down the length of
the intestinal tract is also of interest. Many high permeability
drugs are assumed to be absorbed mainly within the proximal
small intestine, namely, the duodenum and upper jejunum, and
as such, many physiological measurements such as pH and bile
salt concentration are performed within this region. There is
also known segmental permeation of some drugs due to the pH
of the intestinal ﬂuid within a speciﬁc region of the intestinal
tract and/or the presence of diﬀerent types of transporters.41,42
The amount of water available in the intestine will also be
relevant for unconventional or enterically coated tablets.
According to this study the highest percentage of ﬂuid exists
within the distal regions of the small intestine, such as the distal
duodenum and proximal and distal ileum. Therefore, it may be
that for drugs to absorb in the duodenum and proximal
jejunum they must be in solution upon entry into the small
intestine or dissolve rapidly in the upper small intestine and be
subsequently rapidly absorbed into the membrane.
Figure 4. Graphical representation of number and volume of small
bowel water pockets for three subjects. The small intestine is
represented as a cylinder. Shaded areas represent liquid pockets.
The minimum (1.4 mL, Subject 14), near median (21.3 mL, Subject
07), and maximum (160.1 mL, Subject 11) small bowel water volumes
at fasting baseline (before administration of the study dose of water)
are shown to illustrate schematically the high interindividual variability.
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■ CONCLUSIONS
This study is the ﬁrst to quantify total volume and distribution
of liquid in the stomach and small intestine under conditions
representing BA/BE studies using a validated MRI method-
ology. Results conﬁrmed the existence of discontinuous liquid
pockets within the small intestinal tract, a phenomenon
recently suggested by Schiller and co-workers.15 Here, gastric
emptying rate, volumes, numbers, and locations of liquid
pockets present in the upper gastrointestinal tract were
determined as a function of time after administration of a
standard testing volume of 240 mL of water in 12 healthy
volunteers in the fasted state. The information collected has
important implications for the rates and extents of dissolution,
precipitation, and absorption of oral dosage forms in vivo in the
gastrointestinal tract and can be used to develop biorelevant
dissolution methodologies, as well as mechanistic computa-
tional transport analyses for oral bioperformance prediction.
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